Diana Ernst, RPh

Editorial Director

Diana Ernst, RPh, is the Editorial Director for MPR, part of the Haymarket Medical Network. Since 2003, Diana has worked to provide healthcare professionals with up-to-date drug information through MPR's print and digital offerings. She is a graduate of the Ernest Mario School of Pharmacy, Rutgers University.

All articles by Diana Ernst, RPh

Allergies

FDA Expands Use of Bioelectronic Device ClearUp to Include Sinus Congestion

Diana Ernst, RPh

April 8, 2021

The bioelectronic device was previously approved for treating sinus pain due to allergic rhinitis.

Obstructive Lung Disease

Mannitol Inhalation Powder Now Available as Add-On Maintenance Therapy for Cystic Fibrosis

Diana Ernst, RPh

April 6, 2021

Bronchitol should only be used by adults who have passed the Bronchitol Tolerance Test.

Lung Infection

Pediatric Trial Evaluating Moderna’s COVID-19 Vaccine Begins

Diana Ernst, RPh

March 26, 2021

The phase 2/3 KidCOVE study [ClinicalTrials.gov: NCT04796896] is evaluating the safety and effectiveness of the vaccine in healthy children between 6 months and less than 12 years of age.

Lung Cancer

Lorbrena Approved for First-Line Treatment of ALK-Positive Metastatic NSCLC

Diana Ernst, RPh

March 17, 2021

Lorbrena is a third generation ALK tyrosine kinase inhibitor.

Lung Infection

CDC Provides Guidance for Individuals Fully Vaccinated Against COVID-19

Diana Ernst, RPh

March 17, 2021

Fully vaccinated individuals can visit with other fully vaccinated people, or unvaccinated people from a single household who are at low risk for severe COVID-19 disease, indoors without wearing masks or physical distancing.